Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Stockholders Equity
$7.17B
Quarterly · Period ending: · USD
BIO Stockholders Equity
Latest reported$7.17Bperiod ending
Latest reported$7.17Bperiod ending
BIO Quarterly Shareholders Equity ($29.90M → $7.17B)
Quarterly shareholders equity
High-resolution chart · PNG
BIO stockholders equity history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stockholders Equity (USD) |
|---|---|
| 256,334,000 | |
| 247,265,000 | |
| 244,618,000 | |
| 228,704,000 | |
| 222,342,000 | |
| 218,998,000 | |
| 220,100,000 | |
| 234,200,000 | |
| 228,800,000 | |
| 220,900,000 | |
| 214,300,000 | |
| 212,000,000 | |
| 210,300,000 | |
| 207,400,000 | |
| 196,700,000 | |
| 194,800,000 | |
| 194,400,000 | |
| 187,700,000 | |
| 183,500,000 | |
| 181,000,000 | |
| 174,100,000 | |
| 166,300,000 | |
| 157,100,000 | |
| 151,400,000 | |
| 147,100,000 | |
| 139,900,000 | |
| 129,800,000 | |
| 125,600,000 | |
| 121,200,000 | |
| 117,600,000 | |
| 110,300,000 | |
| 111,900,000 | |
| 111,100,000 | |
| 110,700,000 | |
| 107,100,000 | |
| 108,000,000 | |
| 105,400,000 | |
| 95,200,000 | |
| 90,800,000 | |
| 88,400,000 | |
| 85,900,000 | |
| 85,500,000 | |
| 81,100,000 | |
| 77,200,000 | |
| 76,600,000 | |
| 74,300,000 | |
| 68,900,000 | |
| 66,500,000 | |
| 64,400,000 | |
| 59,500,000 | |
| 50,100,000 | |
| 43,300,000 | |
| 29,900,000 |